Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Volavka

Showing results (81-90 of 146) with videos related to

Pageof 15
Sort By:
Diseases of the Nervous System|November 1, 1970
Lateralized EEG changes afterunilateral and bilateral eectroconvulsive therapyR Abrams, J Volavka, J Roubicek, et al.
Psychopharmacology|January 1, 1981
Effect of piracetam on EEG spectra of boys with learning disordersJ Volavka, J Simeon, S Simeon, et al.
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 1985
The EEG in persons at risk for alcoholismJ Volavka, V Pollock, W F Gabrielli, et al.
International Pharmacopsychiatry|January 1, 1978
Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studiesB Saletu, J Grünberger, M Saletu, et al.
The American Journal of Psychiatry|June 1, 1988
Videotape recording of inpatient assaults: a pilot studyD A Brizer, M L Crowner, A Convit, et al.
Biological Psychiatry|February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?W T Carpenter, J M Zito, J Vitrai, et al.
Psychiatric Genetics|February 24, 2001
An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorderK A Nolan, J Volavka, H M Lachman, et al.
Schizophrenia Bulletin|January 1, 1996
Placebo washout in trials of antipsychotic drugsJ Volavka, T B Cooper, E M Laska, et al.
Clinical Pharmacology and Therapeutics|September 1, 1976
Naltrexone: disposition, metabolism, and effects after acute and chronic dosingK Verebey, J Volavka, S J Mulé, et al.
The American Journal of Psychiatry|June 1, 1974
Studies of EN-1639A (naltrexone): a new narcotic antagonistR B Resnick, J Volavka, A M Freedman, et al.
Pageof 15

Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Diseases of the Nervous System|November 1, 1970
Lateralized EEG changes afterunilateral and bilateral eectroconvulsive therapyR Abrams, J Volavka, J Roubicek, et al.
Psychopharmacology|January 1, 1981
Effect of piracetam on EEG spectra of boys with learning disordersJ Volavka, J Simeon, S Simeon, et al.
Recent Developments in Alcoholism : an Official Publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism|January 1, 1985
The EEG in persons at risk for alcoholismJ Volavka, V Pollock, W F Gabrielli, et al.
International Pharmacopsychiatry|January 1, 1978
Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studiesB Saletu, J Grünberger, M Saletu, et al.
The American Journal of Psychiatry|June 1, 1988
Videotape recording of inpatient assaults: a pilot studyD A Brizer, M L Crowner, A Convit, et al.
Biological Psychiatry|February 25, 1998
Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?W T Carpenter, J M Zito, J Vitrai, et al.
Psychiatric Genetics|February 24, 2001
An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorderK A Nolan, J Volavka, H M Lachman, et al.
Schizophrenia Bulletin|January 1, 1996
Placebo washout in trials of antipsychotic drugsJ Volavka, T B Cooper, E M Laska, et al.
Clinical Pharmacology and Therapeutics|September 1, 1976
Naltrexone: disposition, metabolism, and effects after acute and chronic dosingK Verebey, J Volavka, S J Mulé, et al.
The American Journal of Psychiatry|June 1, 1974
Studies of EN-1639A (naltrexone): a new narcotic antagonistR B Resnick, J Volavka, A M Freedman, et al.
Pageof 15